Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Feb 24 | EGRX Eagle Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 6.27 | 2,119 | 13.29 k | 460,621 |
27 Feb 24 | EGRX Eagle Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 6.44 | 3,154 | 20.31 k | 462,740 |
27 Feb 24 | EGRX Eagle Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 12,950 | 0.00 | 465,894 |
5 Jan 24 | EGRX Eagle Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 5.13 | 4,322 | 22.17 k | 541,125 |
2 Nov 23 | EGRX Eagle Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 13.87 | 10,694 | 148.33 k | 545,447 |
1 Nov 23 | EGRX Eagle Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 13.82 | 10,925 | 150.98 k | 556,141 |
3 Oct 23 | EGRX Eagle Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 15.11 | 710 | 10.73 k | 567,066 |
3 Oct 23 | EGRX Eagle Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 14.41 | 10,024 | 144.45 k | 567,776 |
2 Oct 23 | EGRX Eagle Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 15.23 | 9,511 | 144.85 k | 577,800 |